245 related articles for article (PubMed ID: 31469053)
21. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules.
Fuller MY; Mody D; Hull A; Pepper K; Hendrickson H; Olsen R
Arch Pathol Lab Med; 2018 Feb; 142(2):178-183. PubMed ID: 28537807
[TBL] [Abstract][Full Text] [Related]
22. BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis.
Trimboli P; Treglia G; Condorelli E; Romanelli F; Crescenzi A; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2016 Mar; 84(3):315-20. PubMed ID: 25920006
[TBL] [Abstract][Full Text] [Related]
23. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
24. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.
Eszlinger M; Krogdahl A; Münz S; Rehfeld C; Precht Jensen EM; Ferraz C; Bösenberg E; Drieschner N; Scholz M; Hegedüs L; Paschke R
Thyroid; 2014 Feb; 24(2):305-13. PubMed ID: 23837487
[TBL] [Abstract][Full Text] [Related]
25. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.
Sapio MR; Posca D; Raggioli A; Guerra A; Marotta V; Deandrea M; Motta M; Limone PP; Troncone G; Caleo A; Rossi G; Fenzi G; Vitale M
Clin Endocrinol (Oxf); 2007 May; 66(5):678-83. PubMed ID: 17381488
[TBL] [Abstract][Full Text] [Related]
26. Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
Duick DS
Endocr Pract; 2012; 18(4):611-5. PubMed ID: 22849877
[TBL] [Abstract][Full Text] [Related]
27. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
[TBL] [Abstract][Full Text] [Related]
28. Indeterminate Thyroid Nodules: From Cytology to Molecular Testing.
Vignali P; Macerola E; Poma AM; Sparavelli R; Basolo F
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761374
[TBL] [Abstract][Full Text] [Related]
29. Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients.
Kleiman DA; Sporn MJ; Beninato T; Crowley MJ; Nguyen A; Uccelli A; Scognamiglio T; Zarnegar R; Fahey TJ
Cancer; 2013 Apr; 119(8):1495-502. PubMed ID: 23280049
[TBL] [Abstract][Full Text] [Related]
30. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
31. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
32. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
33. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
[TBL] [Abstract][Full Text] [Related]
34. The utility of ThyroSeq
Li W; Justice-Clark T; Cohen MB
Cytopathology; 2021 Jul; 32(4):505-512. PubMed ID: 33914382
[TBL] [Abstract][Full Text] [Related]
35. Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
Stewardson P; Eszlinger M; Wu J; Khalil M; Box A; Perizzolo M; Punjwani Z; Ziehr B; Sanyal R; Demetrick DJ; Paschke R
Thyroid; 2023 Dec; 33(12):1423-1433. PubMed ID: 37742115
[No Abstract] [Full Text] [Related]
36. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
37. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
Kim SK; Hwang TS; Yoo YB; Han HS; Kim DL; Song KH; Lim SD; Kim WS; Paik NS
J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
[TBL] [Abstract][Full Text] [Related]
38. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
Lee EJ; Song KH; Kim DL; Jang YM; Hwang TS; Kim SK
Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
[TBL] [Abstract][Full Text] [Related]
39. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
Eszlinger M; Hegedüs L; Paschke R
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis.
Jia Y; Yu Y; Li X; Wei S; Zheng X; Yang X; Zhao J; Xia T; Gao M
Diagn Cytopathol; 2014 Jan; 42(1):94-101. PubMed ID: 24167125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]